<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82918">
  <stage>Registered</stage>
  <submitdate>20/06/2008</submitdate>
  <approvaldate>1/12/2008</approvaldate>
  <actrnumber>ACTRN12608000596303</actrnumber>
  <trial_identification>
    <studytitle>Cystocele and Stress Urinary Incontinence(SUI):Simultaneous repair (Sim-Pair) by a modified surgical technique using transobturator mesh -Prospective study</studytitle>
    <scientifictitle>Cystocele and Stress Urinary Incontinence(SUI):Simultaneous repair (Sim-Pair) by a modified surgical technique using transobturator mesh -Prospective study</scientifictitle>
    <utrn />
    <trialacronym>SIM-PAIR study</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Stress urinary incontinence</healthcondition>
    <healthcondition>Vaginal wall prolapse</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Simultaneous repair of cystocoele and treatment of SUI using Transobturator Mesh system(Perigee) via anterior vaginal wall incision and 4 exit points in the crural fold bilaterally (2 on each side). Patients are then followed up for a total of 24 months.</interventions>
    <comparator>None</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Absence of Urodynamic stress incontinence(USI) and less than Stage 2 prolapse using Pelvic Organ Prolapse Quantification (POP-Q).</outcome>
      <timepoint>Outcome is measured at baseline.Follow up at 3,6,12,24 months after surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Operation time</outcome>
      <timepoint>On the day of operation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of hospital stay</outcome>
      <timepoint>From day of surgery until discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Intra and postoperative complications; eg haemorrhage, infection, bladder and urethral injury, voiding dysfunction, mesh exposure or erosion.</outcome>
      <timepoint>Intraoperative and over the period 24 months of postoperative period</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life questionnaires:Bristol Female lower urinary tract symptom (BFLUTS), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</outcome>
      <timepoint>3,6,12,24 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient subjective assessment of improvement; BFLUTS &amp; PISQ.Main indicators being improvement of symptoms and quality of life.</outcome>
      <timepoint>3,6,12,24 months after surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women presenting with stage 2 or more bladder prolapse (cystocele) and Stress Urinary Incontinence[revealed and occult] who desire reconstructive surgery,</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women with less than stage 2 prolapseWomen who do not demonstrate SUIWomen with Intrinsic sphincter deficiency ( defined as maximum urethral closure pressure of more than orequal to 20 cm of water)Women less than 18 yrsWomen who decline participationWomen unable to give informed consentWomen with previous mesh based repair for bladder prolapse</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Pelvic health Education and Research</primarysponsorname>
    <primarysponsoraddress>P O Box 1417
Townsville QLD 4810</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Pelvic health Education and Research</fundingname>
      <fundingaddress>P O Box 1417
Townsville QLD 4810</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a study to assess the efficacy and safety of using one single mesh to treat both bladder prolapse and stress urinary incontinence as one operation.
We hope the cure of stress urinary incontinence(SUI) will be comparable to other meshes used to treat SUI alone.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>21/05/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Kurinji Kannan</name>
      <address>The Townsville Hospital
100 Angus Smith Drive Townsville QLD 4814</address>
      <phone>+61747963759</phone>
      <fax />
      <email>kurinji.kannan@jcu.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Kurinji Kannan</name>
      <address>The Townsville Hospital
100 Angus Smith Drive Townsville QLD 4814</address>
      <phone>+61747963759</phone>
      <fax />
      <email>kurinji.kannan@jcu.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>